Chronic allograft nephropathy: prospective randomised trial of cyclosporin withdrawal and mycophenolate mofetil or tacrolimus substitution-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chronic allograft nephropathy: prospective randomised trial of cyclosporin withdrawal and mycophenolate mofetil or tacrolimus substitution

Published:2001-05 Issue:3 Volume:33 Page:2193-2195
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

McGrath J.S,Shehata M

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference8 articles.

1. Cecka JM, Terasaki PI: In: Clinical Transplants. Los Angeles: United Network for Organ Sharing; 1994, p 1

2. Conversion From Cyclosporine to Tacrolimus in Renal Allograft Recipients With Chronic Graft Nephropathy: Preliminary Report

3. Chronic allograft nephropathy: effect of cyclosporine reduction and addition of mycophenolate mofetil on progression of renal disease

4. A NOVEL APPROACH TO THE TREATMENT OF CHRONIC ALLOGRAFT NEPHROPATHY1

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparison of mycophenolate mofetil and calcineurin inhibitor as maintenance immunosuppression for kidney transplant recipients: A meta-analysis of randomized controlled trials;TURKISH JOURNAL OF MEDICAL SCIENCES;2021-06-28

2. Autologous bone marrow-derived mesenchymal stem cells for interstitial fibrosis and tubular atrophy: a pilot study;Renal Failure;2021-01-01

3. Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients;Cochrane Database of Systematic Reviews;2017-07-21

4. Calcineurin Inhibitor-Sparing Strategies in Renal Transplantation: Where Are We? A Comprehensive Review of the Current Evidence;Experimental and Clinical Transplantation;2016-10

5. Calcineurin inhibitor-sparing regimens based on mycophenolic acid after kidney transplantation;Transplant International;2015-01-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3